Detail Data
Volume (24h): 1,588,637 shares
P/E Ratio: /
Forward P/E: -0.53
EPS: -0.9 USD
Forward EPS: -2.4 USD
Number of Shares: 36,593,200 shares
Market Capitalization: 76,571,728.00 USD

Dividend

Dividend Value
Dividend Amount According to our data, the company IGM Biosciences does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: -
5-Year Avg Yield %: -
Payout Ratio: -
Last Dividend Value: -
Last Dividend Date: -

Analyst Forecast

Most analysts have issued a hold recommendation for IGM Biosciences stock. The current number of analysts covering this company is 2. The highest target price is 1.247 USD, while the lowest target price is 1 USD. The median target valuation set by analysts is 1.1235 USD. These forecasts and recommendations provide insight into how analysts view the future stock performance of IGM Biosciences.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for IGM Biosciences stock is: hold
Number of Analysts: 2
Highest Target Price: 1.247 USD
Lowest Target Price: 1 USD
Median Target Price: 1.1235 USD

Fundamental Indicators

Indicator Data
Total Revenue: 145,050,000.00 USD
Net Income: -53,385,000.00 USD
Price-to-Book (P/B): 0.76
PEG Ratio: /
Exchange: NasdaqGS
Industry: Biotechnology
Sector: Healthcare
Number of Employees: 54
Country: United States

Where to Buy IGM Biosciences Stock?

You can purchase IGM Biosciences stock on the NasdaqGS under the ticker symbol: IGMS. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on IGM Biosciences Stock

Indicator Value
Company Revenue: 145,050,000.00 USD
EBITDA: 17,634,000.00 USD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share: -0.9 USD
Book Value Per Share: 1.68 USD
Total Cash: 104,306,000.00 USD
Total Cash per Share: 1.73 USD
Total Debt: -
Debt to Equity Ratio: -
Quick Ratio 17.30
Current Ratio 17.66
Free Cash Flow 23,011,124.00 USD
Operating Cash Flow -156,512,992.00 USD
Gross Margins -3.79 %
EBITDA Margins 12.16 %
Operating Margins 90.72 %
Profit Margins -36.81 %
Return on Assets 2.9 %
Return on Equity -47.8 %
Earnings Growth (1 year) -
Revenue Growth (1 year) 11,353.2 %
Quarterly Earnings Year-over-Year Growth -
Market Capitalization 76,571,728.00 USD
Enterprise Value -27,734,288.00 USD
EV/Revenue -0.191
EV/EBITDA -1.573
Float Shares 24,353,422 shares
Shares Outstanding 36,593,200 shares
Held Percent Insiders 0.35 %
Held Percent Institutions 46.88 %
Shares Short 452,126
Shares Short Prior Month 393,583
Date Short Interest 2025-07-31
Short Percentage of Total Shares 0.75 %
Short Ratio 0.38
Beta 0.59
Short Percentage of Float 2.11 %
Implied Shares Outstanding 60,767,400

Frequently Asked Questions (FAQ)

According to our data, the company IGM Biosciences does not pay dividends yet, even in 2025.

IGM Biosciences shares are traded on the NasdaqGS stock exchange under the ticker: IGMS. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

According to our data, the recommendation for IGM Biosciences shares is from a total of 2 analysts. The average target price prediction is 1.1235 USD per share.

The total number of IGM Biosciences shares on the exchange is 36,593,200.00 shares, which at the current market capitalization gives the company a total valuation of 76,571,728.00 USD.